Your browser doesn't support javascript.
loading
[The First Russian Consensus on the Multilevel Abobotulinumtoxin A Injections in Spastic Forms of Cerebral Palsy]. / Pervyi Rossiiskii konsensus po primeneniyu mnogourovnevykh in''ektsii abobotulinumtoxin A pri lechenii spasticheskikh form detskogo tserebral'nogo paralicha.
Kurenkov, A L; Klochkova, O A; Zmanovskaya, V A; Falkovskiy, I V; Kenis, V M; Vladykina, L N; Krasavina, D A; Nosko, A S; Rychkova, L V; Karimova, Kh M; Bursagova, B I; Namazova-Baranova, L S; Mamedyarov, A M; Kuzenkova, L M; Dontzov, O G; Ryzhenkov, M A; Butorina, M N; Pavlova, O L; Harlamova, N N; Dankov, D M; Levitina, E V; Popkov, D A; Ryabykh, S O; Medvedeva, S N; Gubina, E B; Agranovich, O V; Kiseleva, T I; Vasileva, O N; Zykov, V P; Mihnovich, V I; Belogorova, Т А.
Afiliação
  • Kurenkov AL; Scientific Centre of Children's Health of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Klochkova OA; Scientific Centre of Children's Health of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Zmanovskaya VA; Center for Restorative Treatment and Rehabilitation 'Nadezhda', Tymen, Russia.
  • Falkovskiy IV; 'Neyroklinika' LLC, Khabarovsk, Russia.
  • Kenis VM; Federal State Budgetary Institution 'The Turner Scientific Research Institute for Children's Orthopedics' under the Ministry of the Health of the Russian Federation, Saint-Petersburg, Russia.
  • Vladykina LN; Altai regional mental hospital for children, Regional state budget health facility, Barnaul, Russia.
  • Krasavina DA; State budget institution of higher professional education Saint-Petersburg State Pediatric Medical University under the Ministry of Health of the Russian Federation, Department of surgical diseases of childhood, Saint-Petersburg, Russia.
  • Nosko AS; SBEI APE Russian Medical Academy of Postgraduate Education MPH, Department of neurology, Moscow, Russia; Group of Companies European Medical Center, Moscow, Russia.
  • Rychkova LV; Federal State Public Scientific Institution 'Scientific Сentre for Family Health and Human Reproduction Problems', Irkutsk, Russia.
  • Karimova KM; Scientific Centre of Children's Health of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Bursagova BI; Scientific Centre of Children's Health of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Namazova-Baranova LS; Scientific Centre of Children's Health of the Ministry of Health of the Russian Federation, Moscow, Russia; Sechenov First Moscow Medical State University, Department of allergology and clinical immunology, Moscow, Russia; Pirogov Russian National Scientific Research Medical University, department o
  • Mamedyarov AM; Scientific Centre of Children's Health of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Kuzenkova LM; Scientific Centre of Children's Health of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Dontzov OG; 'Neyroklinika' LLC, Khabarovsk, Russia.
  • Ryzhenkov MA; 'Neyroklinika' LLC, Khabarovsk, Russia.
  • Butorina MN; Center for Restorative Treatment and Rehabilitation 'Nadezhda', Tymen, Russia.
  • Pavlova OL; Center for Restorative Treatment and Rehabilitation 'Nadezhda', Tymen, Russia.
  • Harlamova NN; Center for Restorative Treatment and Rehabilitation 'Nadezhda', Tymen, Russia.
  • Dankov DM; Center for Restorative Treatment and Rehabilitation 'Nadezhda', Tymen, Russia.
  • Levitina EV; Tyumen State Medical University, Department of neurology, Tyumen, Russia.
  • Popkov DA; The Federal State-Financed Institution 'Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics of the RF Ministry of Health', Kurgan, Russia.
  • Ryabykh SO; The Federal State-Financed Institution 'Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics of the RF Ministry of Health', Kurgan, Russia.
  • Medvedeva SN; The Federal State-Financed Institution 'Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics of the RF Ministry of Health', Kurgan, Russia.
  • Gubina EB; Kurgan Regional Children Hospital Named after Red Cross, Kurgan, Russia.
  • Agranovich OV; Regional Child Hospital, Stavropol, Russia.
  • Kiseleva TI; Federal State Budgetary Institution 'The Turner Scientific Research Institute for Children's Orthopedics' under the Ministry of the Health of the Russian Federation, Saint-Petersburg, Russia.
  • Vasileva ON; State budget institution of higher professional education Saint-Petersburg State Pediatric Medical University under the Ministry of Health of the Russian Federation, Department of surgical diseases of childhood, Saint-Petersburg, Russia.
  • Zykov VP; SBEI APE Russian Medical Academy of Postgraduate Education MPH, Department of neurology, Moscow, Russia.
  • Mihnovich VI; Federal State Public Scientific Institution 'Scientific Сentre for Family Health and Human Reproduction Problems', Irkutsk, Russia.
  • Belogorova ТА; Federal State Public Scientific Institution 'Scientific Сentre for Family Health and Human Reproduction Problems', Irkutsk, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova ; 116(11): 121-130, 2016.
Article em Ru | MEDLINE | ID: mdl-28091513
ABSTRACT
Spasticity treatment is one of the key aspects of the contemporary cerebral palsy (CP) rehabilitation that influences on the effectiveness of other methods. The paper presents the first Russian document that unites the recommendations for the BTA treatment of CP and could be used as the guideline for the multilevel injections. The Russian consensus on the multilevel botulinum toxin A (BTA) treatment of spastic CP is based on the international data and the results of national studies. The authors describe typical CP spasticity patterns in the upper and lower extremities, give recommended intervals for the BTA (Abobotulinum toxin A) dosages for the whole injection procedure and for the separate muscles. The method of dosage calculation for functional segments is also described. Attention is paid to the frequency, optimal intervals between the repeated injections and the whole duration of BTA treatment. The authors discuss effectiveness and safety of BTA, factors that potentially influence the results of the injections, including ultrasound and electromyography control, and indications for the continuation and termination of treatment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Cerebral / Toxinas Botulínicas Tipo A / Espasticidade Muscular / Fármacos Neuromusculares Tipo de estudo: Etiology_studies / Guideline Limite: Child / Child, preschool / Female / Humans / Male País/Região como assunto: Asia / Europa Idioma: Ru Revista: Zh Nevrol Psikhiatr Im S S Korsakova Assunto da revista: NEUROLOGIA / PSIQUIATRIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Federação Russa

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Cerebral / Toxinas Botulínicas Tipo A / Espasticidade Muscular / Fármacos Neuromusculares Tipo de estudo: Etiology_studies / Guideline Limite: Child / Child, preschool / Female / Humans / Male País/Região como assunto: Asia / Europa Idioma: Ru Revista: Zh Nevrol Psikhiatr Im S S Korsakova Assunto da revista: NEUROLOGIA / PSIQUIATRIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Federação Russa
...